I have had a cold for five days and I feel wrecked. Why no Amoxil 875 mg?
The board splits on the organism, not the misery
Claim: if you feel terrible, you have earned Amoxil 875 mg. Strike: severity is not a culture.
Amoxicillin blocks bacteria from finishing a peptidoglycan wall. That mechanism only helps when a susceptible bacterium is the cause. Sore throat, cough, blocked nose, fever - none of those symptoms tell you whether a virus or a bacterium is in charge, and viruses win most outpatient weeks. A sound antibacterial decision starts with the likely pathogen. Feeling wrecked with a viral cold does not make 875 mg work any better against it. Which is to say: at all.
It also pays to rank the evidence instead of lumping every indication into one 'reviews' pile. The strongest uses rest on guideline consensus and trials showing cure or shorter illness against a confirmed bacterial target. Others are reasonable by convention and local resistance. A large third bucket - viral illness - has been tested and settled. Antibacterials add nothing. Keeping those tiers separate is the whole fact line.
A review that only lists 'uses' without the strike column is a shopping list. This desk files both. Mechanism and labelled strengths sit on the Amoxil 875 mg fact line. If a reader came here because a forum said 875 mg 'covers everything in the head,' that claim is already dead. The tablet covers susceptible bacteria. It does not cover a virus, and it does not cover a feeling.
Group A strep: the review that still holds
Strep pharyngitis is the cleanest match this drug has. Group A streptococcus (Streptococcus pyogenes) has never produced a documented clinical isolate resistant to penicillin or amoxicillin. CDC clinical guidance still says that out loud. IDSA still lists penicillin or amoxicillin as first-line for confirmed GAS in people who are not allergic. The point of treatment is not only a shorter sore throat. It is also to cut the already-rare risk of acute rheumatic fever and to reduce spread in a household.
Clinical exam cannot reliably separate viral pharyngitis from GAS when viral features are absent. Cough, rhinorrhoea, hoarseness, and oral ulcers point viral and usually mean do not swab. Fever, tender anterior nodes, and tonsillar exudate without those viral marks raise the pretest enough to test. A rapid antigen detection test or a throat culture is what earns the tablet. A weekend of pain does not.
In children 3 years and older, a negative rapid test still wants a backup throat culture, because a missed GAS case is the one that matters for rheumatic fever. Adults with a negative rapid test and no high-risk features usually stop there. CDC dosing for amoxicillin in GAS is often 50 mg/kg once daily (max 1000 mg) for 10 days, or 25 mg/kg twice daily. Adults on this desk often see 875 mg twice daily as a convenient labelled row, but the duration that still matters for rheumatic-fever prevention is the full 10-day course, not a three-day 'I feel better' stop. Practical numbers live on the 875 mg allergy-triage card.
Ears, true bacterial sinus, outpatient lung
| Condition | What the evidence actually says | Amoxicillin's job |
|---|---|---|
| GAS pharyngitis (confirmed) | No penicillin-resistant clinical GAS; IDSA/CDC first-line | Treat and cut rheumatic-fever risk |
| Acute otitis media | Guidelines plus trials; many mild cases self-resolve | First-line when treated, often high-dose |
| Acute bacterial sinusitis | Guidelines; diagnose by time course, not mucus colour | First-line (plain or with clavulanate) |
| Outpatient pneumonia, healthy adult | Guidelines; pneumococcus still the typical target | First-line 875 mg every 12 hours on many labels |
| H. pylori (in a regimen) | Strong as a teammate, never as monotherapy | The low-resistance partner |
| Dental abscess | Source control first; drug is backup | First-line antibacterial when one is needed |
| Common cold / influenza | Settled: no benefit | No role |
| Acute bronchitis, healthy adult | Trials: little or no benefit | Usually not indicated |
Acute otitis media is the paediatric textbook. When an antibacterial is warranted, high-dose amoxicillin is still the recommended first choice because Streptococcus pneumoniae remains the main target and the drug penetrates middle-ear fluid. Many mild cases resolve without any antibacterial, which is why watchful waiting is often the smarter first move. When treatment is needed, this is the drug, not a reflex macrolide.
Acute bacterial sinusitis, when it is truly bacterial and not a lingering cold, responds to amoxicillin or co-amoxiclav. The pattern that points bacterial is symptoms past about ten days without improvement, or a clear get-better-then-crash, often with focal facial pain and fever. Colour of mucus is not that pattern. For community-acquired pneumonia in otherwise healthy outpatients, many guidelines still open with amoxicillin because pneumococcus is the usual typical organism and often remains susceptible. Lower-respiratory rows on the US tablet label already sit at 875 mg every 12 hours even when the illness is called mild or moderate. That is a labelled strength, not a forum upgrade.
H. pylori and dental work: teammate jobs, not solo cures
Amoxicillin anchors many regimens that eradicate Helicobacter pylori, the stomach organism behind most peptic ulcers. It is never used alone for that job. It rides with a proton pump inhibitor and one or two other antibacterials, typically clarithromycin or metronidazole, because H. pylori is hard to clear and single agents breed resistance. Amoxicillin earns the roster spot because resistance to it in H. pylori stays relatively low. It is the dependable teammate, not the star.
In dentistry, amoxicillin is the usual first choice when a dental infection genuinely needs an antibacterial - a spreading abscess, systemic signs, spreading cellulitis. The drug is backup. The real fix for most dental abscesses is drainage or removing the source. Amoxicillin without that dental work treats the wrong problem and often delays the procedure that would have ended the pain. Source control first, tablet as support. That order is the same principle surgery uses everywhere else.
Colds, flu, green mucus, winter bronchitis: the strike list
This is the indication 875 mg gets requested for most and helps with least. State it without padding.
Colds, influenza, most sore throats, most acute bronchitis, and most early sinus congestion are viral. Amoxicillin has no mechanism against a virus. Taking it for a cold does not shorten illness, does not stop a viral infection 'turning bacterial,' and does not speed return to work. What it does is expose you to diarrhoea, rash, and the occasional allergic reaction for zero gain, while nudging your own flora toward resistance. Green or yellow nasal mucus is a normal phase of a viral cold as neutrophils break down. It is not a culture.
Prescribing 'just in case' is a major driver of resistance, and a real harm, not a seminar slogan. Every unnecessary course selects for tougher bacteria in that person and the community. The CDC's Be Antibiotics Aware programme at the CDC and the WHO antimicrobial-resistance pages at WHO repeat the same line: antibacterials do not work on viruses, and using them when they are not needed makes them work less well when they are. How Beecham even made an honest oral tablet is a different file - the Brockham Park engineering note.
Stewardship on this desk: the narrowest agent that works
| Penicillin V | Amoxicillin | Co-amoxiclav | |
|---|---|---|---|
| Type | Natural penicillin | Aminopenicillin | Amoxicillin plus clavulanate |
| Spectrum | Narrow, mostly gram-positive | Broader, some gram-negative | Adds many enzyme producers |
| Beats beta-lactamase? | No | No | Yes, clavulanate blocks many enzymes |
| Typical first-line for | Confirmed strep | Ear, sinus, pneumonia, strep, H. pylori | Sinus, bites, resistant respiratory cases |
| Main downside | Narrow reach; frequent dosing | No cover vs enzyme bugs | More diarrhoea; easy to overuse |
Antibiotic stewardship sounds like a committee. The working rule is simple. Use an antibacterial only when bacterial infection is likely. Pick the narrowest drug that reliably covers the probable organism. Give the right dose for the right duration. Stop. Amoxicillin fits that model for the infections above, which is exactly why guidelines keep it first-line instead of defaulting to a broader, newer agent.
Reaching for a broad-spectrum tablet when a narrow one would do is not being thorough. It is being wasteful. It accelerates resistance and raises the risk of Clostridioides difficile diarrhoea. Choosing plain amoxicillin versus co-amoxiclav is a stewardship decision in miniature: add clavulanate only when beta-lactamase producers are genuinely likely, not because 875 mg 'feels stronger' with a partner. Strength is milligrams and susceptibility, not the number of names on the box.
Reader mail
Reader questions on this article
Answered by Dr. Marcus Bellinger, MD · Internal medicine & infectious disease
These are the evidence claims readers keep sending after a viral week. I answered them at full length.
Because it will not help, and I would only be exposing you to real downsides. A cold is viral. Amoxicillin has no pathway to act on a virus. It will not shorten the illness or prevent it becoming something worse. Feeling awful for five days is miserable and normal with a bad cold. Severity is not a sign of bacterial infection. What the tablet would do is give you a genuine chance of diarrhoea or rash and push your own bacteria toward resistance, all for no benefit. If specific red flags appear - high fever returning after you were improving, one-sided facial or ear pain, or breathing trouble - that changes the picture and I want you seen again. The CDC explains the viral-versus-bacterial split at the CDC.
My mucus turned green. Doesn't that mean I need the antibiotic now?
It is one of the most common requests and one of the most persistent false claims. Green or yellow mucus is what happens partway through an ordinary viral cold as immune cells break down and colour the secretions. It does not mean the infection turned bacterial. It does not mean you have earned 875 mg. Studies linking mucus colour to antibacterial benefit find no useful connection. What actually points toward bacterial sinusitis is a different pattern: symptoms dragging past ten days without improving, or getting clearly better then sharply worse, often with facial pain and fever. Colour alone does not decide it. File the colour as a phase, not a culture.
For strep throat, is amoxicillin better than plain penicillin?
Both are excellent. Penicillin remains the reference standard. Amoxicillin is often chosen for convenience. Group A strep has never developed meaningful resistance to either, which is remarkable and means both reliably work. Amoxicillin tends to win in children because the liquid tastes better and can be given less often, which helps families finish a 10-day course. Finishing matters here, partly to prevent rheumatic fever. So one is not 'stronger.' Amoxicillin is frequently easier to take, and an antibacterial that gets taken beats a slightly narrower one that sits in the cupboard. Adults on this desk often see 875 mg twice daily as a convenient labelled row once GAS is confirmed.
Why do H. pylori treatments use amoxicillin plus other drugs instead of just one?
Because H. pylori is genuinely hard to clear and single antibacterials fail, both from resistance and from the harsh acidic stomach. Combining amoxicillin with a proton pump inhibitor and one or two other agents, usually clarithromycin or metronidazole, attacks the organism from several angles and delivers a real cure rate. Amoxicillin earns its central role because resistance to it in H. pylori stays relatively low. It is the dependable teammate. Using it alone would just breed resistance and leave the ulcer unhealed. MedlinePlus has a readable overview of the infection at MedlinePlus if you want background without a regimen card.
My dentist gave me amoxicillin but also insisted on draining the abscess. Wasn't the pill enough?
Your dentist had the order right, and drainage is the more important half. For most dental abscesses the real cure is getting pus out and dealing with the source, whether that means draining, root-canal work, or removing the tooth. The antibacterial is backup when infection is spreading or you have systemic signs like fever. It cannot fix what drainage is meant to solve. Amoxicillin without the dental work treats the wrong thing and often delays proper care. Source control first, tablet as support. That order is correct, and it is the same principle across surgery. The pill is not a substitute for the procedure.
Is amoxicillin useful for bronchitis? I get it every winter and it always clears up on antibiotics.
Timing tricks us here. Acute bronchitis in an otherwise healthy adult is almost always viral, and trials show antibacterials give little or no benefit while causing side effects. It seems to clear up on amoxicillin because bronchitis improves on its own over one to three weeks regardless. Whatever you took last gets the credit. Real exceptions exist: if you have a chronic lung condition like COPD and are flaring, or signs point to pneumonia, antibacterials can genuinely matter, and that is a different file. For plain bronchitis in healthy lungs, the evidence says skip the blister. Feeling better after a viral week is not a review of 875 mg.
Should I keep leftover Amoxil to start early next time I get sick?
No. Finish or discard leftovers rather than stockpiling. Self-starting creates several problems. You cannot tell whether your next illness is bacterial or viral, and most are viral, so you would often take it for nothing. A partial leftover course is the wrong dose and duration - one of the ways resistance is bred. You might treat the wrong organism entirely and delay proper care. Antibacterials are among the few medicines where using them on spec harms not just you but the wider community. If you get sick, get assessed and let the diagnosis choose the drug. The WHO explains the resistance stakes at WHO.
Do I need a test before every sore throat, or can you just treat me?
If the picture is clearly viral - cough, runny nose, hoarseness, mouth ulcers - I do not swab and I do not treat. If the picture could be GAS, I test. Clinical scoring helps me decide who is low enough probability that a swab is wasted. It is not a licence to treat on vibes. IDSA and CDC both want microbiological confirmation in ordinary-risk patients before an antibacterial. Empiric 875 mg for an untested sore throat is how people collect an EBV rash and a false penicillin-allergy label. Confirm, then treat. That is the review that holds. The labelled tablet itself is on the Amoxil fact line.
If pneumococcus is getting tougher, shouldn't I skip amoxicillin and start something broader?
Not as a first move. Some pneumococci show reduced penicillin susceptibility by altering the binding target, not by making beta-lactamase. The targeted answer is often more amoxicillin - high-dose in children, 875 mg every 12 hours in many adult respiratory rows - not an automatic leap to a broader class. Broader agents cost more collateral flora and more C. difficile risk. Guidelines keep high-dose amoxicillin first for many ear and lung cases for that reason. If local resistance, recent antibacterials, or severity push you off the narrow agent, that is a different stewardship call, often toward co-amoxiclav. It is not a reason to treat a virus with anything.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated